NSE: AJANTPHARM · Healthcare · Pharmaceuticals · Market cap ₹41,912 Cr
· Prev close ₹3,338.20 · Volume 94.41 K · 52W ₹2,446–3,796
Day range for 9 Nov not in the price history yet · 8 Nov ₹3,310.00–3,343.90
Last 4 quarters: profit +29.2% on the 4 beforeShare price −2.8% in a month
If profit compounds at 10.3% (CAGR) and the stock ends at 25×, buying at ₹3,355 returns about 7.2% CAGR over 10 years.
| Growth assumption | Profit growth (CAGR) | Return, 10Y CAGR |
|---|---|---|
| Yours | 10.3% | 7.2% |
| Delivered FY22–26 | 10.3% | 7.2% |
| Net profit, last 4 quarters vs the 4 before | 29.2% | 25.6% |
| Half the delivered pace | 5.2% | 2.2% |
Delivered FY22–26 CAGR 10.3%
This is an exit-multiple calculation, not a discounted cash flow. Inputs: EPS for the 4 quarters Dec 2025 to Sep 2026 ₹101.08, price ₹3,354.70 (9 Nov 2026, 12:45 pm IST price). Formula: return = (EPS × exit P/E ÷ price)^(1/10) × (1 + growth) − 1. Net profit growth is applied to EPS, so the share count is held constant. A profit fall of 100% or more has no rate and is left blank. Dividends ignored. Arithmetic, not a forecast.